Salk Institute for Biological Studies Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2012
NCT01759940
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Salk Institute for Biological Studies